U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H21N5O4
Molecular Weight 335.3583
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-CYCLOPENTYLADENOSINE

SMILES

OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3NC4CCCC4

InChI

InChIKey=SQMWSBKSHWARHU-SDBHATRESA-N
InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
6.3 nM [EC50]
Name Type Language
N-CYCLOPENTYLADENOSINE
Common Name English
(2R,3R,4S,5R)-2-(6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL
Systematic Name English
N(6)-CYCLOPENTYLADENOSINE
Systematic Name English
ADENOSINE, N-CYCLOPENTYL-
Common Name English
UK-80882
Code English
Code System Code Type Description
PUBCHEM
657378
Created by admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
PRIMARY
CAS
41552-82-3
Created by admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
PRIMARY
WIKIPEDIA
N6-Cyclopentyladenosine
Created by admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
PRIMARY
FDA UNII
7LG47VG1ID
Created by admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID80961807
Created by admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
PRIMARY